Picture of VG Life Sciences logo

VGLS VG Life Sciences Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for VG Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2010
December 31st
C2011
December 31st
C2012
December 31st
2013
December 31st
2014
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PRESSARS10-Q10-Q10-K
Standards:
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-7.24-5.42-6.85-7.42-6.19
Depreciation
Non-Cash Items5.553.113.863.44.44
Other Non-Cash Items
Changes in Working Capital0.6081.292.032.98-0.161
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-1.01-1.02-0.96-1.04-1.91
Capital Expenditures00000
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items00000
Other Investing Cash Flow
Cash from Investing Activities00000
Financing Cash Flow Items00.1250
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities11.020.961.751.23
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.009-0.00100.708-0.68